Clinical Trial Update: Plasma Exchange for Renal Vasculitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating plasma exchange for renal vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Wegener's Granulomatosis, Microscopic Polyangiitis | Phase 2, Phase 3 | Status: TERMINATED